GlassScriptPhysician profile
Oliver T Newcomb
NPI 1811262207
$3,364.28
in general payments reported to CMS, 2019-2025
30 companies · $638 in 2025
The $638 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $267 · 2021: $338 · 2022: $444 · 2023: $508 · 2024: $651 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,648 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.56 |
| Education | $150.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $696.19 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $572.73 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $321.03 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $199.01 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $169.14 | 2020-2022 | |
| Neotract INC. | $165.13 | 2019 | |
| Procept Biorobotics Corporation | $159.08 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Urovant Sciences INC | $133.59 | 2022 | |
| Axonics, INC. | $130.88 | 2021-2024 | Axonics |
| Guerbet LLC | $107.59 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.76 | 2020-2025 | |
| Urogen Pharma, INC. | $75.12 | 2025 | |
| Telix Pharmaceuticals | $67.45 | 2023-2024 | Illuccix |
| Novartis Pharmaceuticals Corporation | $65.66 | 2024-2025 | |
| Ambu INC. | $53.70 | 2022-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $47.70 | 2024 | |
| Convatec INC. | $47.41 | 2023-2024 | |
| C. R. Bard, INC. & Subsidiaries | $31.77 | 2025 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $28.35 | 2019-2025 | Axonics |
| Progenics Pharmaceuticals, INC. | $22.98 | 2025 | |
| Olympus America INC. | $22.41 | 2025 | Itind System |
| Myovant Sciences INC. | $22.04 | 2022 | |
| Abbvie INC. | $17.46 | 2022 | |
| Myriad Genetic Laboratories, INC. | $17.12 | 2023 | Prolaris |
| Davol INC. | $16.96 | 2025 | Arista |
| Astrazeneca Pharmaceuticals LP | $16.77 | 2023 | |
| Angiodynamics, INC. | $16.20 | 2024 | Nanoknife |
| Azurity Pharmaceuticals, INC. | $15.04 | 2025 | Azmiro |
| Teleflex LLC | $14.05 | 2021 | |
| Coloplast Corp | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Newcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.